The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the lot number was not provided.The reported patient effects of stenosis, headache and hypertension are listed in the xact carotid stent system information for prescribers as adverse events potentially associated with carotid stents and embolic protection systems.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The date of event is estimated as (b)(6) 2022.The date of implant is estimated as (b)(6) 2022.
|
It was reporter that the 10x30 mm xact carotid stent was implanted one year ago in the left internal carotid with heavy calcification.Approximately 6 months after the stent was implanted, the patient began experiencing headaches, dizziness and hypertension and in-stent restenosis was confirmed.The patient was attempted to be treated medically; however, the medication did not seem to alleviate any of the symptoms.A ct scan was performed and it was decided to place another stent on (b)(6) 2023 to treat the in stent restenosis.There were no reported adverse patient sequela.No additional information was provided.
|